A Phase II clinical trial is currently underway to evaluate the efficacy of retinal progenitor cells in treating a retinitis pigmentosa that causes visual impairment and, in severe cases, blindness. In an earlier clinical trial, the stem cells were used to create new photo receptors, with patients reporting improvements in vision. In follow-ups conducted between 18 days and 2 months following treatment, patients were able to read three additional lines in a standard eye test chart.
The clinical trials are being conducted at the Retinal Research Institute in Arizona and the US- Massachusetts Eye and Ear Clinic in Boston. Participants are currently being recruited for further stages of the trial. Additionally, the progress of this treatment should offer researchers insight into other progressive degenerative disorders, and the technique of restoring the delicate retinal tissues could be applied to a broader range of treatments for cataracts, glaucoma and other age related degeneration.
To learn more about stem cells, and how families can bank their own valuable stem cells by recovering the very powerful dental pulp stem cells during routine dental procedures; such as wisdom teeth extractions or the during the loss of baby teeth, visit StemSave or call 877-783-6728 (877-StemSave) today.
The Future of Regenerative Medicine is Now™
To view the full article, click here